EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease

Marcello Marchetta iD, Stefano Sasso iD, Vincenzo Paragliola, Valerio Maffi iD, Gaetano Chiricolo iD, Gianluca Massaro iD, Giulio Russo iD, Daniela Benedetto, Saverio Muscoli iD, Giuseppe Colonna, Alessandro Mandurino-Mirizzi iD, Bernardo Cortese iD und 2 weitere

Journal of Cardiovascular Development and Disease · 05.05.2025 · 12 (5) · 176

DOI: 10.3390/jcdd12050176 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 05.05.2025. Verfasst von Marcello Marchetta und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-coated balloons (DCBs) have emerged as a promising alternative therapeutic strategy to traditional drug-eluting stent (DES) implantation in various coronary artery lesion scenarios, aiming to minimize complications associated with permanent metallic scaffolds, such as chronic inflammation, delayed vessel healing, and stent thrombosis. This review systematically evaluates the current clinical evidence supporting the use of DCBs across diverse anatomical and clinical contexts, including small-vessel disease, in-stent restenosis, bifurcation lesions, diffuse coronary lesions, acute coronary syndromes, and chronic total occlusions, as well as in special patient populations such as individuals with diabetes mellitus or at high bleeding risk. The literature analysis incorporated recent randomized controlled trials, observational studies, and real-world registries, highlighting the clinical efficacy, safety profiles, and specific advantages of DCB angioplasty. The findings consistently demonstrated non-inferior clinical outcomes of DCBs compared to DESs across multiple lesion types, with particular benefits observed in special populations, including reduced restenosis rates and comparable major adverse cardiac events (MACEs). Nevertheless, clinical data gaps remain, emphasizing the need for larger, longer-term randomized trials to refine patient selection and procedural techniques. In conclusion, DCB angioplasty represents a viable and effective alternative to conventional stenting, particularly advantageous in complex lesions and specific patient subsets, pending further definitive evidence.

Schlagwörter

Stichwörter der Autor:innen

acute coronary syndromescomplex morphologiescoronary angioplastycoronary artery diseasediabetes mellitusdrug-coated balloonsdrug-eluting stentshigh hemorrhagic riskpercutaneous coronary intervention

Autor:innen und Institutionen

  • Department of Clinical and Experimental Medicine, University of Messina, 98122 Messina, Italy.
  • Department of Biomedicine and Prevention, University of Rome "Tor Vergata", 00133 Roma, Italy.
  • Division of Cardiology, "V. Fazzi" Hospital, 73100 Lecce, Italy.
  • Fondazione Ricerca e Innovazione Cardiovascolare, 20143 Milan, Italy.
  • DCB Academy, 20143 Milan, Italy.
  • University Hospitals Harrington Heart and Vascular Institute, Cleveland, OH 44106, USA.

ORCID-Profile: Marcello Marchetta, Stefano Sasso, Valerio Maffi, Gaetano Chiricolo, Gianluca Massaro, Giulio Russo, Saverio Muscoli, Alessandro Mandurino-Mirizzi, Bernardo Cortese, Giuseppe Massimo Sangiorgi, Giuseppe Andò

Zitieren

APA

Marchetta, M., Sasso, S., Paragliola, V., Maffi, V., Chiricolo, G., Massaro, G., Russo, G., Benedetto, D., Muscoli, S., Colonna, G., Mandurino-Mirizzi, A., Cortese, B., Sangiorgi, G. M., & Andò, G. (2025). Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease. Journal of Cardiovascular Development and Disease, 12(5), 176. https://doi.org/10.3390/jcdd12050176

Vancouver

Marchetta M, Sasso S, Paragliola V, Maffi V, Chiricolo G, Massaro G, et al. Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease. Journal of Cardiovascular Development and Disease. 2025;12(5):176. doi:10.3390/jcdd12050176

BibTeX
@article{Marchetta2025,
  author = {Marchetta, Marcello and Sasso, Stefano and Paragliola, Vincenzo and Maffi, Valerio and Chiricolo, Gaetano and Massaro, Gianluca and Russo, Giulio and Benedetto, Daniela and Muscoli, Saverio and Colonna, Giuseppe and Mandurino-Mirizzi, Alessandro and Cortese, Bernardo and Sangiorgi, Giuseppe Massimo and Andò, Giuseppe},
  title = {Leaving Nothing Behind: Expanding the Clinical Frontiers of Drug-Coated Balloon Angioplasty in Coronary Artery Disease},
  journal = {Journal of Cardiovascular Development and Disease},
  year = {2025},
  volume = {12},
  number = {5},
  pages = {176},
  doi = {10.3390/jcdd12050176}
}
Kostenlos starten →